Literature DB >> 546907

Determination of labetalol in human plasma by high-performance liquid chromatography.

L J Dusci, L P Hackett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 546907     DOI： 10.1016/s0021-9673(00)86420-1

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  4 in total

Review 1.  Clinical pharmacokinetics of labetalol.

Authors:  J J McNeil; W J Louis
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

Review 2.  Labetalol. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in hypertension and ischaemic heart disease.

Authors:  K L Goa; P Benfield; E M Sorkin
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

3.  Elimination kinetics of labetalol in severe renal failure.

Authors:  A J Wood; D G Ferry; R R Bailey
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

Review 4.  Pharmacology of combined alpha-beta-blockade. I.

Authors:  W J Louis; J J McNeil; O H Drummer
Journal:  Drugs       Date:  1984       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.